Blocking molecules involved in ALS-drug resistance may improve how well ALS therapeutics work, suggesting that re-evaluation of drugs that appeared to have failed might be appropriate.
Blocking molecules involved in ALS-drug resistance may improve how well ALS therapeutics work, suggesting that re-evaluation of drugs that appeared to have failed might be appropriate.